<table border="1" class="dataframe">
  <thead>
    <tr>
      <th></th>
      <th></th>
      <th colspan="5" halign="left">Grouped by Diabetes history</th>
    </tr>
    <tr>
      <th></th>
      <th></th>
      <th>Missing</th>
      <th>Overall</th>
      <th>No Prior Diabetes</th>
      <th>Prior Diabetes</th>
      <th>P-Value</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>n</th>
      <th></th>
      <td></td>
      <td>5814</td>
      <td>306</td>
      <td>5508</td>
      <td></td>
    </tr>
    <tr>
      <th>Age, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>72.0 [69.0,75.0]</td>
      <td>70.0 [68.0,73.0]</td>
      <td>72.0 [69.0,75.0]</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">Sex, n (%)</th>
      <th>Female</th>
      <td></td>
      <td>2986 (51.4)</td>
      <td>223 (72.9)</td>
      <td>2763 (50.2)</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>Male</th>
      <td></td>
      <td>2828 (48.6)</td>
      <td>83 (27.1)</td>
      <td>2745 (49.8)</td>
      <td></td>
    </tr>
    <tr>
      <th rowspan="3" valign="top">First semaglutide - brand name, n (%)</th>
      <th>Ozempic</th>
      <td></td>
      <td>4510 (77.6)</td>
      <td>246 (80.4)</td>
      <td>4264 (77.4)</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>RYBELSUS</th>
      <td></td>
      <td>1290 (22.2)</td>
      <td>51 (16.7)</td>
      <td>1239 (22.5)</td>
      <td></td>
    </tr>
    <tr>
      <th>WEGOVY</th>
      <td></td>
      <td>14 (0.2)</td>
      <td>9 (2.9)</td>
      <td>5 (0.1)</td>
      <td></td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">First semaglutide - dosage form, n (%)</th>
      <th>INJECTION, SOLUTION</th>
      <td></td>
      <td>4524 (77.8)</td>
      <td>255 (83.3)</td>
      <td>4269 (77.5)</td>
      <td>0.020</td>
    </tr>
    <tr>
      <th>TABLET</th>
      <td></td>
      <td>1290 (22.2)</td>
      <td>51 (16.7)</td>
      <td>1239 (22.5)</td>
      <td></td>
    </tr>
    <tr>
      <th>First semaglutide - total payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>851.3 [769.3,1536.3]</td>
      <td>1051.4 [799.6,1457.9]</td>
      <td>847.2 [768.2,1536.3]</td>
      <td>0.064</td>
    </tr>
    <tr>
      <th>First semaglutide - out-of-pocket payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>40.2 [0.0,60.0]</td>
      <td>45.0 [15.0,75.0]</td>
      <td>40.0 [0.0,56.0]</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>Average monthly total payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>1612.7 [1032.0,2523.0]</td>
      <td>1000.9 [635.3,1604.2]</td>
      <td>1652.8 [1068.0,2574.7]</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>Average monthly out-of-pocket payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>88.6 [55.6,134.0]</td>
      <td>77.3 [46.8,112.1]</td>
      <td>89.2 [56.0,135.3]</td>
      <td>&lt;0.001</td>
    </tr>
  </tbody>
</table>